Semaglutide, a drug used for diabetes and weight loss, might help reduce opioid overdoses in people with OUD and T2D.

People using semaglutide, a common drug for diabetes and weight loss, may experience ... of a minor risk, given their limited data. Their investigation is still in progress. Link between eating ...

Researchers from the University of Liverpool have found that the weight-loss drug tirzepatide could significantly reduce the ...

Semaglutide, sold as Wegovy and Ozempic, may reduce opioid overdoses in people with opioid-use disorder and type 2 diabetes.

Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated ... impact the long-term weight loss of patients with ...

semaglutide may promote weight loss and decrease the risk of cancer, diabetes and cardiovascular disease in individuals with obesity or overweight. “Ozempic is a safe medication with a variety ...

has not only proven effective in treating weight loss and diabetes: Mounting evidence suggests these drugs may be effective at treating other conditions like cancer, Alzheimer’s and COVID-19.

Key Factors That Impact Long-Term Weight Loss in Patients Prescribed GLP-1 RA Medications ... Link Found Between Heme Iron, Found in Red Meat and Other Animal Products, and Type 2 Diabetes Risk ...

The trials tested the weight-loss drug in obese people with or without Type 2 diabetes ... ago Falls linked to increased risk of dementia in older people Cognitive decline may increase an older ...

A trial found that patients who took it alongside diet and exercise typically lost a fifth of their body weight in 36 weeks.

The weight-loss drug liraglutide helped ... belly fat Obesity increases risk of severe infection, especially in diabetes patients Wegovy, Ozempic may someday be available as monthly injection ...